Categories: BioTechBuildingDevelopmentLivingProductResearch
Apogee Therapeutics, LLC is a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the millions of people living with immunological and inflammatory disorders.
Location: United States, California, San Francisco
Investors 2
Funding Rounds 2
Date | Series | Amount | Investors |
12.03.2024 | - | $483M | - |
12.12.2022 | Series B | $149M | - |
Mentions in press and media 8
Date | Title | Description | Source |
13.03.2024 | Apogee Therapeutics, Inc. Closes Public Offering with Record... | Apogee Therapeutics, Inc. (Nasdaq: APGE) has successfully completed a public offering, raising a sta... | parsers.vc... |
12.03.2024 | Apogee Therapeutics, Inc. Announces Closing of Upsized Publi... | - | globenewsw... |
12.03.2024 | Apogee Therapeutics, Inc. Announces Closing of Upsized Publi... | SAN FRANCISCO, Calif. and WALTHAM, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, In... | einpresswi... |
07.03.2024 | Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 ... | - | globenewsw... |
05.03.2024 | Apogee Therapeutics Provides Pipeline Progress and Reports F... | - | globenewsw... |
05.03.2024 | Apogee Therapeutics, Inc. Announces Proposed Underwritten Pu... | - | globenewsw... |
12.12.2022 | Apogee Therapeutics Raises $149M in Series B; $169M in Total | Apogee Therapeutics, a San Francisco, CA-based biotechnology company, raised $149M in Series B fundi... | finsmes.co... |
- | Apogee Therapeutics | “Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients'... | fastfounde... |
Reviews 0